Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally. The impact of statins on liver fibrosis severity in MASLD individuals remains uncertain, despite their known cardiovascular benefits. Methods: A cross-secti...

Full description

Bibliographic Details

Published in:	Livers
Main Authors:	Natchaya Polpichai, Sakditad Saowapa, Aunchalee Jaroenlapnopparat, Leandro Sierra, Pojsakorn Danpanichkul, Panisara Fangsaard, Phuuwadith Wattanachayakul, Apichat Kaewdech
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Subjects:	Statins MASLD NAFLD MASH NASH liver fibrosis
Online Access:	https://www.mdpi.com/2673-4389/4/4/46